Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
12/27/2001 | CA2413866A1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
12/27/2001 | CA2413253A1 Matrix protein compositions for dentin regeneration |
12/27/2001 | CA2412734A1 Renal regulatory elements and methods of use thereof |
12/27/2001 | CA2412215A1 Angiogenesis-modulating compositions and uses |
12/27/2001 | CA2410632A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
12/26/2001 | CN1328469A Use of parvovirus capsid particles in inhibition of cell proliferation and migration |
12/26/2001 | CN1328468A Bacteriostatic compositions for salmonellae |
12/26/2001 | CN1327851A Caspule for dispelling wind and detoxicating body |
12/26/2001 | CN1327847A Chinese medicine compound preparation for treating enuresis and preparing process thereof |
12/26/2001 | CN1327841A Medicine for treating rheumatoid arthritis |
12/26/2001 | CN1327835A Medicine for treating cerebral thrombus and its preparing process |
12/26/2001 | CN1327833A Exterior-applied ointment for treating piles |
12/26/2001 | CN1327820A Lotion for treating anal diseases |
12/26/2001 | CN1327817A Antiabortifacient for treating male endocrine sterility and its preparing process |
12/26/2001 | CN1327816A Antiabortifacient for treating acyesis and sterility and its preparing process |
12/26/2001 | CN1327807A Chinese medicine for treating neoplasm |
12/26/2001 | CN1327800A Composite Chinese medicine for treating prostatitis, impotence and ejaculation praecox and its preparing process |
12/26/2001 | CN1327798A Process for preparing low-peptide mixer by controlled enzymolysis of snake |
12/26/2001 | CN1327797A Process for preparing medicine to treat cerebral thrombus and its sequelae |
12/26/2001 | CN1327796A Medicine for treating cervical vertebra disease by injection method |
12/26/2001 | CN1076621C Capsule for treatment of rheumatic angitis and its preparation method |
12/26/2001 | CN1076619C Moxiburning medicine for acupoint therapy |
12/26/2001 | CN1076617C Medicine specially for treating caput femoris necrosis, and method for preparing same |
12/26/2001 | CN1076615C Chinese medicine powder for setting bone |
12/26/2001 | CN1076612C Chinese-medicinal instant particles for promoting milk secretion and recovery of puerperant |
12/26/2001 | CN1076610C Mongolia patent drug for treating peptide ulcer |
12/26/2001 | CN1076609C Chinese medicine for curing gastritis and duodenal ulcer |
12/26/2001 | CN1076596C Tartaric acid nutritious honey capable of balancing blood pressure |
12/26/2001 | CN1076586C Mucosal competitive exclosion flora |
12/25/2001 | US6333188 Lactic acid bacteria preparation having biopurification activity |
12/25/2001 | US6333051 Nanogel networks and biological agent compositions thereof |
12/25/2001 | US6333041 Nontoxic vernix compositions and method of producing |
12/25/2001 | US6333030 Chimeric retrovirus/adenovirus system |
12/25/2001 | CA2186775C Ribosome fraction and composition containing the same |
12/25/2001 | CA2176258C Device and method for photoactivation |
12/20/2001 | WO2001096393A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
12/20/2001 | WO2001096390A2 Compositions and methods for the therapy and diagnosis of colon cancer |
12/20/2001 | WO2001096388A2 Compositions and methods for the therapy and diagnosis of colon cancer |
12/20/2001 | WO2001095919A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses |
12/20/2001 | WO2001095918A1 A process for producing and packaging lactic acid bacteria tablets |
12/20/2001 | WO2001095917A2 Kefir extract as an anti-cancer agent |
12/20/2001 | WO2001095861A2 Transdifferentiation of glial cells |
12/20/2001 | WO2001095831A2 Cardiac disease treatment and device |
12/20/2001 | WO2001095815A1 Integrated herd management system utilizing isolated populations of x-chromosome bearing and y-chromosome bearing spermatozoa |
12/20/2001 | WO2001095739A2 Diet which induces ketosis in a canine or feline |
12/20/2001 | WO2001088108A8 Neuronal serine-threonine protein kinase |
12/20/2001 | WO2001053518A3 Method of assessing the viability of a cell |
12/20/2001 | WO2001050872A3 Method for produce sanitation using bacteriophages |
12/20/2001 | WO2001049254A3 Method for producing a cosmetically applicable marine mud extract and product containing said marine mud extract |
12/20/2001 | WO2000060076A3 Compositions for the treatment and diagnosis of breast cancer and methods for their use |
12/20/2001 | WO2000008133A9 NOVEL G PROTEIN-COUPLED RECEPTOR cDNA SEQUENCE |
12/20/2001 | WO1997012960A3 Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in a bio-artificial liver system |
12/20/2001 | US20010053800 Long chain monounsaturated alcohol mixtures |
12/20/2001 | US20010053769 Use of pro-apoptotic factors in treatment of atherosclerosis |
12/20/2001 | US20010053768 Gene therapy using replication competent targeted adenoviral vectors |
12/20/2001 | US20010053549 Loading method |
12/20/2001 | US20010053547 Method for preparing a platelet composition |
12/20/2001 | US20010053362 Tolerizing the immune system of a non-human animal with antigens from said subject, and thereafter transplanting the bone marrow of said subject with the bone marrow of said tolerized immune system. |
12/20/2001 | US20010053361 Immunotherapy involving cd28 stimulation |
12/20/2001 | US20010053355 Treated monocytes incubated to maximize number of functional dendritic cells; then incubated with disease effector agents to enhance the presentation of at least one disease-causing antigen expressed by the disease effector agents. |
12/20/2001 | US20010053354 Porcine cardiomyocytes and their use in treatment of insufficient cardiac function |
12/20/2001 | US20010053353 Injectable polysaccharide-cell compositions |
12/20/2001 | US20010053352 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
12/20/2001 | DE10024171A1 Neuronale Serin-Threonin-Protein-Kinase Neuronal serine threonine protein kinase |
12/20/2001 | CA2417131A1 Kefir extract as an anti-cancer agent |
12/20/2001 | CA2412223A1 Compositions and methods for the therapy and diagnosis of colon cancer |
12/20/2001 | CA2411462A1 Integrated herd management system utilizing isolated populations of x-chromosome bearing and y-chromosome bearing spermatozoa |
12/20/2001 | CA2411278A1 Compositions and methods for the therapy and diagnosis of colon cancer |
12/20/2001 | CA2410532A1 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
12/20/2001 | CA2351275A1 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances |
12/19/2001 | EP1164196A1 Retroviral vectors |
12/19/2001 | EP1163905A1 Skin preparations for external use |
12/19/2001 | EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites |
12/19/2001 | EP1163355A1 Anti-neoplastic viral agents comprising toxin gene under control of tumour cell-derived transcription factors |
12/19/2001 | EP1163332A1 48 human secreted proteins |
12/19/2001 | EP1163326A1 Methods of microencapsulating pancreatic islet cells |
12/19/2001 | EP1163252A2 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene |
12/19/2001 | EP1163008A1 Use of trehalose for stabilising a liquid vaccine |
12/19/2001 | EP1163006A1 Method to prevent xenograft transplant rejection |
12/19/2001 | EP1163004A2 Immunoadsorber for use in sepsis therapy |
12/19/2001 | EP1163000A2 Vaccine against antigens from bacteriae |
12/19/2001 | EP1162999A2 Vaccine against Streptococcus pneumoniae |
12/19/2001 | EP1162998A2 Vaccine against streptococcus pneumoniae capsular polysaccharides |
12/19/2001 | EP1162987A1 Pharmaceutical composition for medical and veterinary use for regenerating intestinal flora in diarrhoea or dyspeptic syndrome |
12/19/2001 | EP1162986A1 Lactobacillus strains preventing diarrhoea caused pathogenic bacteria |
12/19/2001 | EP1162985A1 Matrix protein compositions for induction of apoptosis |
12/19/2001 | EP1162968A1 Use of epigallocatechin-gallate for inhibiting angiogenesis |
12/19/2001 | EP1162952A1 Cytoprotective biocompatible containment systems for biologically active materials and methods of making same |
12/19/2001 | EP1162890A1 A method of preventing parturient hypocalcemia in animals and compositions used therein |
12/19/2001 | EP0979093B1 Arrestable therapeutic viral agent |
12/19/2001 | EP0935605A4 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
12/19/2001 | EP0758387B1 Thymidine kinase mutants |
12/19/2001 | EP0746624B1 Vector for liver-specific gene expression |
12/19/2001 | EP0714305B1 Composition and method for stimulation of reproductive performance |
12/19/2001 | EP0535021B1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
12/19/2001 | CN1326780A Medicinal capsule for cuirng male sterility and its preparing process |
12/19/2001 | CN1326774A Compound brain nourishing liquid and its preparing method |
12/19/2001 | CN1326773A Medicine for curing hyperosteogeny |
12/19/2001 | CN1326766A Blood cooling and psoriasis cleaning Chinese patent medicine capsule for curing psoriasis |
12/19/2001 | CN1326762A Chinese patent medicine for preventing and curing cancer |